International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

PreScription: Standardized Concentrations: Pro or Con?

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2018 - Volume 22, Number 6
View All Articles in Issue

Page(s): 444

PreScription: Standardized Concentrations: Pro or Con? Page 1

Download in electronic PDF format for $75

Abstract:

Related Keywords: Loyd V. Allen, Jr., PhD,RPh, standardized drug concentrations, drug safety, pediatric formulations

Related Categories: PARENTERALS, PEDIATRICS, ADVERSE DRUG EVENTS, HOSPITAL PHARMACY, PROFESSIONAL ISSUES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
PreScription: Standardized Concentrations: Pro or Con? Allen Loyd V Jr	Nov/Dec 2018 Pg. 444
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety Allen W Chris, Greeson Nicole MH, Mixon William	Nov/Dec 2020 Pg. 451-458
Basics of Compounding: Standardization of Compounded Medications Allen Loyd V Jr	Jan/Feb 2019 Pg. 35-44
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions Svirskis Darren, Lin Shao-Wei, Brown Helen, Sangaroomthong Annie, Shin Daniel, Wang Ziqi, Xu Hongtao, Dean Rebecca, Vareed Preetika, Jensen Maree, Wu Zimei	Mar/Apr 2018 Pg. 164-171
PreScription: Discontinued Drugs and Drug Shortages Allen Loyd V Jr	Mar/Apr 2011 Pg. 92
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A	Nov/Dec 2011 Pg. 526-527
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Allen Loyd V Jr	Jan/Feb 2020 Pg. 44-50
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Allen Loyd V Jr	Nov/Dec 2006 Pg. 446-448
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
PreScription: Factors Related to Drug Waste and Pharmacy Solutions Allen Loyd V Jr	Jul/Aug 2018 Pg. 268
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations Jasti Bhaskara R, Saraf Poonam	May/Jun 2011 Pg. 259-261
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Allen Loyd V Jr, Ashworth Lisa D	Jan/Feb 2005 Pg. 44-46
Pediatric Compounding: Coloring Outside the Lines Preckshot John	Jan/Feb 2001 Pg. 6-8
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Allen Loyd V Jr, Williams LaVonn A	Jul/Aug 2012 Pg. 294-298
Does Your Drug Expertise Include Clinical Pharmaceutics? Newton David W	May/Jun 2016 Pg. 202-206
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
PreScription: Drug Shortages and Discontinued Drugs Allen Loyd V Jr	Jul/Aug 2012 Pg. 268
PreScription: Compounded Drugs Often Become Manufactured Drugs Allen Loyd V Jr	Nov/Dec 2022 Pg. 444
Return to Top